Herbals in the control of ageing

Drug Discovery Today

Volumn 14, Issue 19-20, 2009, Pages 992-998

  Kapoor, Vijay K ^a   Dureja, Janhvi ^a   Chadha, Renu ^b  

^a GHG Khalsa College of Pharmacy   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; ALPHA TOCOPHEROL; ANTHRAQUINONE DERIVATIVE; ANTIOXIDANT; AZADIRACHTA INDICA EXTRACT; BIOSTIM; BORAGE OIL; BROMOCRIPTINE; CATECHIN; CHOLINE ALFOSCERATE; DIIDOLYLMETHANE; EMBLICA OFFICINALIS EXTRACT; EQUISTAT; ERGOLID MESYLATE DERIVATIVE; ESSENTIAL OIL; HERBACEOUS AGENT; LEVODOPA; MINERAL; PHENOL DERIVATIVE; PHYTOESTROGEN; PLANT GLYCOSIDE; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; RESVERATROL; SILYBUM MARIANUM EXTRACT; TERPENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINPOCETINE; VITAMIN; XANTHONE DERIVATIVE;

AESCULUS HIPPOCASTANUM; AGING; ALOE VERA; ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANGINA PECTORIS; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; BACOPA MONNIERI; BREAST CANCER; CEREBROVASCULAR ACCIDENT; CINNAMON; COGNITIVE DEFECT; COMMON COLD; CONSTIPATION; CORONARY ARTERY DISEASE; CRATAEGUS; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ECHINACEA; EDEMA; FEVER; FOOD INTAKE; GINKGO BILOBA; GINSENG; HEART DISEASE; HEMORRHOID; HUMAN; HYPERICUM PERFORATUM; IMMUNOSTIMULATION; MALIGNANT NEOPLASTIC DISEASE; MEDICINAL PLANT; NEUROBLASTOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; OSTEOPOROSIS; PARKINSON DISEASE; PIPER METHYSTICUM; PLANT LEAF; PLANT ROOT; PLANT SEED; PROSTATE CANCER; PROSTATE DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; RHEUMATIC DISEASE; SABAL; SILYBUM MARIANUM; SKIN DISEASE; SLEEP DISORDER; TEA; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT DISEASE; URTICA DIOICA; VALERIANA; WITHANIA SOMNIFERA; ZINGIBERACEAE;

AGING; ANIMALS; CELL AGING; COMPLEMENTARY THERAPIES; HUMANS; MOLECULAR STRUCTURE; PLANT PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349459727     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.06.014     Document Type: Review

References (90)

1. Sukh Dev. Ayurveda Materia Medica: a treasure trove of biologically active molecules. Proceedings of International Conference on New developments in Drug Discovery from Natural Products and Traditional Medicine. NIPER, S.A.S. Nagar, India (2008)
2. Murray M.T. The Healing Power of Herbs (1995), Prima Publishing pp. 286-293
3. West D.P., and Zhu Y.F. Evaluation of Aloe vera gel gloves in the treatment of dry skin associated with occupational exposure. Am. J. Infect. Control 31 (2003) 40-42
4. Avijgan M. Phytotherapy: an alternative treatment for non-healing ulcers. J. Wound Care 13 (2004) 157-158
5. Vogler B.K., and Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br. J. Gen. Pract. 49 (1999) 823-828
6. Archana R., and Namasivayam A. Antistressor effect of Withania somnifera. J. Ethnopharmacol. 64 (1999) 91-93
7. Devi P.U. Withania somnifera Dunal (Aswagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Ind. J. Exp. Biol. 34 (1996) 927-932
8. Bhattacharya S.K., et al. Antioxidant activity of glycowithanolides from Withania somnifera. Ind. J. Exp. Biol. 35 (1997) 236-239
9. Kulkarni S.K., et al. Gaba receptor mediated anti-convulsant action of Withania somnifera root extract. Ind. Drugs 30 (1993) 305-312
10. Bhattacharya S.K., et al. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother. Res. 14 (2000) 174-179
11. Stough C., et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 156 (2001) 481-484
12. Pilarski R., et al. Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa. J. Ethnopharmacol. 104 (2006) 18-23
13. Skidmore-Roth. Laboratory Handbook of Herbs & Natural Supplements. 2nd edition (2003), Mosby pp. 26-28
14. Singh H.B., et al. Cinnamon bark oil, a potent fungitoxicant against fungi causing respiratory tract mycoses. Allergy 50 (1995) 995-999
15. Nagai H., et al. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). I. Anti-allergic action. Jpn. J. Pharmacol. 32 (1982) 813-822
16. Akira T., et al. Pharmacological studies on the antiulcerogenic activity of Chinese cinnamon. Planta Med. 6 (1986) 440-443
17. Berrio L.F., et al. Insulin activity: stimulatory effects of cinnamon and brewer's yeast as influenced by albumin. Horm. Res. 37 (1992) 225-229
18. Melchart D., et al. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch. Fam. Med. 7 (1998) 541-545
19. Bauer R., and Wagner H. Echinacea species as potential immunostimulatory drugs. In: Wagner H., and Farnsworth N.R. (Eds). Economic and Medicinal Plant Research Vol.5 (1991), Academic Press 253-321
20. Bhattacharya A., et al. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Ind. J. Exp. Biol. 37 (1999) 676-680
21. Le Bars P.L., et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278 (1997) 1327-1332
22. Bastianetto S., et al. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity. Eur. J. Neurosci. 12 (2000) 1882-1890
23. Kleijnen J., and Knipschild P. Ginkgo biloba for cerebral insufficiency. Br. J. Clin. Pharmacol. 34 (1992) 352-358
24. Yoshikawa T., et al. Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid. Redox Signal. 1 (1999) 469-480
25. Liu C.X., and Xiao P.G. Recent advances on ginseng research in China. J. Ethnopharmacol. 36 (1992) 27-38
26. Guo Q., et al. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta 1304 (1996) 210-222
27. Fourneau C., et al. Radical scavenging evaluation of green tea extracts. Phytother. Res. 10 (1996) 529-530
28. Lunder T.L. Catechins of green tea. Antioxidant activity. ACS Sympos. Ser. 507 (1992) 114-120
29. Ho C.T., et al. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prevent. Med. 21 (1992) 520-525
30. Katiyar S.K., and Mukhtar H. Tea antioxidants in cancer chemoprevention. J. Cell. Biochem. Suppl. 27 (1997) 59-67
31. Katiyar S.K., et al. Green tea and skin. Arch. Dermatol. 136 (2000) 989-994
32. Craig A., et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J. Am. Acad. Dermatol. 44 (2001) 425-432
33. Katiyar S.K., et al. Green Tea and skin photoprotection. Cosmet. Toil. 116 (2001) 69-76
34. Ahmad N., et al. Cutaneous photochemoprotection by green tea: a brief review. Skin Pharmacol. Appl. Skin Physiol. 14 (2001) 69-76
35. O'Conolly V.M., et al. Treatment of cardiac performance (NYHA stages I to II) in advanced age with standardized crataegus extract. Forschr. Med. 104 (1986) 805-808
36. Hitzenberger G. The therapeutic effectiveness of chestnut extract [translated from German]. Wien. Med. Wochenschr. 139 (1989) 385-389
37. Fujimura T., et al. A horse chestnut extract, which induces contraction forces in fibroblasts, is a potent anti-aging ingredient. Int. J. Cosmet. Sci. 57 (2006) 369-376
38. Sirtori C.R. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol. Res. 44 (2001) 183-193
39. Guillaume M., and Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittel-Forschung. 44 (1994) 25-35
40. Wilkinson J.A., and Brown A.M.G. Horse chestnut-Aesculus Hippocastanum: potential applications in cosmetic skin-care products. Int. J. Cosmet. Sci. 21 (1999) 437-447
41. Wheatley D. Kava and valerian in the treatment of stress-induced insomnia. Phytother. Res. 15 (2001) 549-551
42. Williams P., et al. Mangostin inhibits the oxidative modification of human low density lipoprotein. Free Rad. Res. 23 (1994) 175-184
43. Stevinson. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Saf. 25 (2002) 251-261
44. Chanarat P., et al. Immunopharmacological activity of Polysaccharide from the Pericarp of Mangosteen Garcinia; Phagocyic intracellular killing activities. J. Med. Assoc. Thai. 80 Suppl 1 (1997) S149-S154
45. Grimm T., et al. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Free Rad. Biol. Med. 36 (2004) 811-822
46. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int. J. Clin. Pharmacol. Ther. 40 (2002) 158-168
47. Altorjay I., et al. The effect of silibinin on the free radical scavenger mechanisms of human erythrocytes in vitro. Acta Physiol. Hung. 80 (1992) 375-380
48. Flora K., et al. Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 93 (1998) 139-143
49. Dehmlow C., et al. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci. 58 (1996) 1591-1600
50. Katiyar S.K., et al. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl. Cancer Inst. 89 (1997) 551-556
51. Sweetman S.C. (ed.) (2007); Passion Flower; Martindale The Complete Drug Reference, 35th Edn., p. 2143
52. Krenn L. Passion flower (Passiflora incarnata L.)-a reliable herbal sedative. Wien. Med. Wochenschr. 152 (2002) 404-406
53. Dhawan K., et al. Antiasthmatic activity of the methanol extract of leaves of Passiflora incarnata. Phytother. Res. 17 (2003) 821-822
54. Dhawan K., and Sharma A. Antitussive activity of the methanol extract of Passiflora incarnata leaves. Fitoterapia 73 (2002) 397-399
55. Dhawan K., et al. Aphrodisiac activity of methanol extract of leaves of Passiflora incarnata Linn in mice. Phytother. Res. 17 (2003) 401-403
56. Barlet A., et al. Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind muticenter study. Wein. Klin. Wochenschr. 102 (1990) 667-673
57. Krzeski T., et al. Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses. Clin. Ther. 15 (1993) 1011-1020
58. Stephen Bent, et al. Saw palmetto for benign prostatic hyperplasia. N. Engl. J. Med. 354 (2006) 557-566
59. Plosker G.L., and Brogden R.N. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging 9 (1996) 379-395
60. Hänsgen K.D., et al. Multicenter double-blind study examining the antidepressant effectiveness of the Hypericum extract. J. Geriatr. Psychiatr. Neurol. Suppl 1 (1994) S12-S14
61. Kasper. Hypericum perforatum-a review of clinical studies. Pharmacopsychiatry 34 (2001) S51-S55
62. Chrubasik S., et al. Evidence for antirheumatic effectiveness of Herba Urticae dioica in acute arthritis: a pilot study. Phytomedicine 4 (1997) 105-108
63. Dathe G., and Schmid H. Phytotherapy of benign prostate hyperplasia (BPH); double-blind study with stinging nettle root extract (Extractum Radicis Urticae-ERU) [translated from German]. Urologe 27 (1987) 223-226
64. Kato K., et al. Stimulation of stress-induced expression of stress proteins by curcumin in cultured cells and in rat tissues in vivo. Cell Stress Chaper. 3 (1998) 152-160
65. Houghton P.J. The scientific basis for the reputed activity of Valerian. J. Pharm. Pharmacol. 51 (1999) 505-512
66. Stevinson C., and Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med. 1 (2000) 91-99
67. Leathwood P.D., et al. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol. Biochem. Behav. 17 (1982) 65-71
68. Acharya S.B., et al. Pharmacological actions of shilajit. Ind. J. Exp. Biol. 26 (1988) 775-777
69. ®) in patients with chronic bronchitis. Int. J. Immunopharmacol. 8 (1986) 589-592
70. Landi G. Oral administration of borage oil in atopic dermatitis. J. Appl. Cosmetol. 11 (1993) 115-120
71. Ziboh V., and Miller C. Essential fatty acids and polyunsaturated fatty acids: significance in cutaneous biology. Annu. Rev. Nutr. 10 (1990) 433-450
72. Chen I., et al. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem. Pharmacol. 51 (1996) 1069-1076
73. Miyazaki K., et al. Genistein and daidzein stimulate hyaluronic acid production in transformed human keratinocyte culture and hairless mouse skin. Skin Pharmacol. Appl. Skin Physiol. 15 (2002) 175-183
74. Liu J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49 (1995) 57-68
75. Emmenhegger H., and Meier Ruge W. The actions of Hydergine on the brain. Pharmacology 1 (1968) 65-78
76. Boula G. Effects of Dihydroerogotoxine mesylate on aging neurons in vitro. Gerontology 24 (1978) 66-70
77. Nishibayashi S., et al. Scavenging effects of dopamine agonists on nitric oxide radicals. J. Neurochem. 67 (1996) 2208-2211
78. Ferraro L., et al. Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by a-glycerylphosphorylcholine. Neurochem. Res. 21 (1996) 547-552
79. Ceda G.P., et al. alpha-Glycerylphosphorylcholine administration increases the GH responses to GHRH of young and elderly subjects. Horm. Metab. Res. 24 (1992) 119-121
80. Cotzias G., et al. Prolongation of the life-span in mice adapted to large amounts of L-dopa. Proc. Nat1. Acad. Sci. U.S.A. 71 (1974) 2466-2469
81. Marshall J., and Berrios N. Movement disorders of aged rats: reversal by dopamine receptor stimulation. Science 206 (1979) 477-479
82. Velasquez M.T., and Bhathena S.J. Dietary phytoestrogens: a possible role in renal disease protection. Am. J. Kidney Dis. 37 (2001) 1056-1068
83. Lamartiniere C.A. Protection against breast cancer with genistein: a component of soy. Am. J. Clin. Nutr. 71 (2000) 1705S-1709S
84. Alarcon C., and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49 (2005) 405-430
85. Frankel E.N., et al. Inhibition of human LDL oxidation by resveratrol. Lancet 41 (1993) 1103-1104
86. Bertelli A.A., et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tiss. React. 17 (1995) 1-3
87. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006) 493-506
88. Delmas D., et al. Resveratrol: preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 49 (2005) 377-395
89. Bradamante S., et al. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 22 (2004) 169-188
90. Feigin V.L., et al. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. Eur. J. Neurol. 8 (2001) 81-85